Attached files
file | filename |
---|---|
EX-10.2 - EX-10.2 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-ex102_15.htm |
EX-32.1 - EX-32.1 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-ex321_6.htm |
EX-31.2 - EX-31.2 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-ex312_9.htm |
EX-31.1 - EX-31.1 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-ex311_8.htm |
EX-10.6 - EX-10.6 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-ex106_359.htm |
EX-10.5 - EX-10.5 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-ex105_12.htm |
EX-10.4 - EX-10.4 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-ex104_16.htm |
EX-10.3 - EX-10.3 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-ex103_14.htm |
EX-10.1 - EX-10.1 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-ex101_250.htm |
10-Q - 10-Q Q3 2018 - HTG MOLECULAR DIAGNOSTICS, INC | htgm-10q_20180930.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of HTG Molecular Diagnostics, Inc. (the “Company”) on Form 10-Q for the quarter ending September 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, to my knowledge that:
|
(1) |
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: November 8, 2018 |
|
By: |
/s/ Shaun D. McMeans |
|
|
|
Shaun D. McMeans |
|
|
|
Chief Financial Officer |
|
|
|
(Principal Financial and Accounting Officer) |